Short Interest & Thesis

Short Interest and Thesis — Goldkey Technology (3135)

Bottom line. No official reported short-interest position exists in this run: Taiwan's TWSE does publish per-stock margin-short (融券) and borrowed-share (借券) balances daily, but none were staged here, and no short-sale-volume, borrow-cost, public net-short, or peer-crowding rows are available. There is also no public short-seller report, activist campaign, accounting allegation, or litigation anywhere in the corpus — a search of every filing returns nothing, and the company itself discloses no pending legal or non-litigation proceedings [1]. So the honest institutional read is that measured short positioning is not decision-useful here. What is decision-useful is the market-structure and dilution setup you can build from the tape and the company's own disclosures: a newly-listed (6 Aug 2025) memory-module name that has run roughly five-fold on a retail-driven, repeatedly limit-up tape, a thin free float, deeply negative operating cash flow funded by serial capital raises, and a live convertible-bond overhang. Those are the real thesis risks — not a crowded short.

Reported positioning — what exists and what does not

Every structured short-interest input staged for 3135 is empty: the manifest reports zero reported-short-interest rows, zero short-sale-volume rows, zero public net-short rows, zero borrow rows, and zero peer rows, with no fetcher configured for this market in the v1 pipeline. That is a coverage gap, not a signal of low short interest. Taiwan is not a dark market — the TWSE and the OTC exchange publish per-security margin short-sale balances (融券餘額) and securities-borrowing-and-lending short sales (借券賣出) on a daily basis — so a reported short-interest series does exist in principle and is the single most valuable thing a later research pass could add. Two structural caveats matter for a name this young: newly-listed Taiwan shares face an initial restriction window before margin financing and short selling are broadly enabled, and Taiwan's 10% daily price limit means shorts caught in the repeated limit-up (漲停) sessions this stock has printed cannot always cover on the day.

No Results

Source: short-interest staging manifest and latest snapshot (reported short interest, short-sale volume, borrow — all staged empty).

Positioning read from the tape (proxy, not short interest)

With no position data, the price/volume tape is the only positioning read available — and it is a loud one. The stock listed on the TWSE main board on 6 August 2025 at an indicative NT$28, opened its first session up 15.54% to NT$32.35, then dropped to limit-down (NT$36.65) within days [2]. From there it has run in a near-vertical, repeatedly limit-up sequence to a NT$266 intraday peak in May 2026, last quoted NT$167 — roughly five times the offer price. This is textbook one-directional retail momentum, not a tape that suggests a crowded, comfortable short.

Loading...

Source: daily price/volume feed as staged (month-end close and average daily share volume); listing detail per news summary [3].

The volume tells the crowding story better than any single price: average daily volume swelled from ~0.24M shares pre-listing to a 6.1–6.3M-share monthly pace during the January and March–May 2026 blow-off. Against roughly 77.5M shares outstanding, that is a daily turnover near 6% of the entire share count — the hallmark of a heavily day-traded retail vehicle. One local outlet flagged the setup directly, noting an AI-memory theme firing while "short-term chip (positioning) pressure remains" [4] — generic technical commentary about profit-taking and share supply, explicitly not a short-interest reading.

Crowding vs liquidity

Shares outstanding (M)

77.5

ADV, 60-day (M shares)

4.82

Daily turnover (ADV / shares)

6.2%

Held by top-10 holders

49.2%

Founder-family related bloc

35.2%

Est. free float (ex top-10)

51.0%

Sources: shares outstanding 77,493,405 [5]; top-10 / family holdings [6]; ADV and turnover derived from the staged price/volume feed. Days to cover is not computable — no reported short interest exists.

Two facts define the crowding math. First, the register is concentrated: the top ten holders own about 49% of the shares, and a founder-family-related bloc — the chairman's investment vehicle at 18.52%, plus related-party vehicles and relatives — exceeds roughly 35% [7]. That leaves a genuinely thin tradable float. Second, that thin float is being turned over at ~6% per day. A low float turned violently is squeeze-prone in both directions: any short that did exist would be hard to cover into limit-up prints, but the same thin float is exactly what let the stock round-trip from NT$266 to NT$167 in six weeks. Days-to-cover cannot be calculated because there is no reported short interest to divide by ADV — stated plainly rather than proxied from volume.

The real overhang — dilution and convertible bonds

The substantive "positioning" risk on this name is not a short book; it is supply of new shares. Goldkey has raised capital repeatedly and carries a live convertible-bond overhang.

Loading...

Source: FY2025 Annual Report, Capital and Shares (share-formation table) [8].

Paid-in shares reached 77,493,405 after the September 2025 IPO cash increase, against 200M authorized [9]. The chairman's stake illustrates the dilution: her vehicle held 28.15% at the last board election but only 18.52% now, as the count expanded [10]. On top of that sits the convertible overhang:

No Results

Source: FY2025 Annual Report, Corporate Bonds (CB #1 and CB #2 terms and conversion) [11]; CB #2 conversion price [12].

The first zero-coupon CB (NT$1bn, issued December 2025, conversion price NT$50.85) was struck well below the runaway share price and has been almost entirely converted — 17,356,828 new shares issued as of 30 April 2026, equal to about 22% of the post-IPO base, with only NT$117.4M left outstanding [13]. That is a large, recent expansion of the share count. The second zero-coupon CB (NT$1.5bn, issued May 2026, conversion price NT$129.9) is still entirely unconverted and is now in the money at the NT$167 tape — a fresh, sizeable dilution and share-supply overhang [14] [15]. Local reporting indicates the company is targeting NT$6–10bn of fundraising in 2026 to secure inventory, so the dilution path is likely not finished.

Short-thesis ledger — built from the company's own disclosures

With no external short report to adjudicate, the disciplined move is to construct the bear case a credible short would make from primary disclosures, and mark what the company says back. Each row separates the risk, the evidence, the company's response, and whether it is unresolved.

No Results

Sources: operating cash flow and FY2026 shortfall [16]; balance-sheet expansion and CB-funded growth [17]; margin/EPS [18]; CB terms [19]; governance and concentration [20] [21]; inflation/memory cost [22].

Two mitigants a short must respect. The company reports no material litigation, non-litigation, or administrative proceedings, and no supplier exceeding 50% of purchases and no sales over-concentration [23]. And because both sales and raw-material purchases are USD-denominated, the company runs a natural FX hedge, limiting currency risk [24]. Profitability is real — FY2025 revenue NT$7,704M, gross margin ~10%, EPS NT$6.33, ROE ~27% [25]. The bear case is a cash-flow, dilution, and cycle-timing case, not a fraud case.

Borrow pressure — no data; one inferred channel

No borrow-cost, utilization, lendable-supply, or hard-to-borrow data was staged, so borrow pressure cannot be assessed directly. One channel is worth flagging as inference, not measurement: zero-coupon convertibles like Goldkey's two CBs typically attract convertible-arbitrage buyers who hedge by borrowing and shorting the underlying stock. That mechanism can create genuine borrow demand and a technical short base tied to the bonds — most plausibly around the fresh, still-outstanding NT$1.5bn CB #2. This is a hypothesis about where any borrow demand would come from, not evidence that a position exists; confirming it requires the TWSE 借券 balance a later research pass should pull.

Evidence quality

No Results

Sources: staging manifests (short interest / borrow — not staged); corpus search (no short-seller report); FY2025 Annual Report for litigation, dilution, and ownership [26] [27].

Setup for the PM. Positioning is not a reason to own or avoid 3135 on measured short interest — there isn't any staged, and no credible short thesis is public. The reasons to size and time carefully are structural: a five-fold, limit-up momentum tape on a thin, founder-controlled float, deeply negative operating cash flow, a self-disclosed FY2026 funding gap plugged by a NT$1.5bn convertible, and continuing dilution. If a later pass pulls the TWSE 融券/借券 balances and they turn out elevated, this flips from a pure dilution-and-cycle story into a genuine crowding question; until then, the risk is de-rating and share supply, not a squeeze.